Caveat to protein replacement therapy for genetic disease. Immunological implications of accurate molecular diagnosis.
D000568:Amenorrhea / Q000188:drug therapy; D000592:Amino Acid Metabolism, Inborn Errors / Q000276:immunology; D000818:Animals; D000937:Antigen-Antibody Reactions; D001803:Blood Transfusion; D003429:Cross Reactions; D004392:Dwarfism / Q000188:drug therapy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D030342:Genetic Diseases, Inborn / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D013006:Growth Hormone / Q000627:therapeutic use; D006168:Guinea Pigs; D006801:Humans; D007118:Immunoassay; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007153:Immunologic Deficiency Syndromes / Q000175:diagnosis / Q000628:therapy*; D007986:Luteinizing Hormone / Q000627:therapeutic use; D008297:Male; D008661:Metabolism, Inborn Errors / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D009154:Mutation; D011506:Proteins / Q000378:metabolism / Q000627:therapeutic use*; D011817:Rabbits
D011506:Proteins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013006:Growth Hormone